Skip to main content
Explore URMC



Publications & Presentations



  1. Magnuson, A., Lemelman, T., Pandya, C., Goodman, M., Noel, M., Tejani, M., Doughtery, D., Dale, W., Hurria, A., Janelsins, M., Lin, V., Heckler, C.E., Mohile, S (2017) “Geriatric Assessment with Management Intervention in Older Adults with Cancer: A Randomized Pilot Study.” Journal of Geriatric Oncology. PMID: 28914366.
  2. Williams, A., Shah, R., Shayne, M., Huston, A., Murray, N., Thompson, B., Hyland, S., Moynihan, J., Cory-Slechta, D.A., Janelsins, M.C. (2017)Associations Between Inflammatory Markers and Cognitive Function in Breast Cancer Patients Receiving Chemotherapy From A Pilot Study.”  Journal of Neuro Immunology. PMID: 29128118.
  3. Kleckner, I.R., Kamen, C., Gewandter, J.S., Mohile, N.A., Heckler, C.E., Culakova, E., Fung, C., Janelsins, M.C., Asare, M., Lin, P.J., Reddy, P.S., Giguere, J., Berenberg, J., Kesler, S.R., Mustian, K.M. (2017) “Effects of Exercise During Chemotherapy on Chemotherapy- Induced Peripheral Neuropathy: A Multicenter Randomized Controlled Trial.” Supportive Care in Cancer, (In Press).
  4. Williams, A.M., Baran, A.M., Meacham, P.J., Feldman, M.M., Valencia, H.E., Newson-Stewart, C., Gupta, N., Janelsins, M.C., Barr, P.M., Zent, C.S. (2017) “Analysis of the Risk of Infection in Patients with Chronic Lymphocytic Leukemia in the Era of Novel Therapies.” Leukemia & Lymphoma. 2017 Jul 11; 1-8, e-pub ahead of print. PMID: 28696801.
  5. Kamen, C., Scheiber, C., Janelsins, M.C., Jo, B., Shen, H., Palesh, O. (2017) “Effects of Childhoof Trauma Exposure and Cortisol Levels On Cognitive Functioning Among Breast Cancer Survivors.” Child Abuse & Neglect, (In Press).
  6. Janelsins, M.C., Heckler, C.E., Peppone, L.J., Kamen, C.,  Mustian, K.M., Mohile, S.G., Magnuson, A., Kleckner, I.R., Guido, J.J., Young, K.L., Conlin, A.K., Weiselberg, L.R., Mitchel, J.W., Ambrosone, C.A., Ahles, T.A., Morrow, G.R. (2017) “Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.” Journal of Clinical Oncology. PMCID: PMC5455314. Impact Factor: 20.98.
  7. Peoples, A.R., Garland, S.N., Perlis, M.L., Savard, J., Heckler, C.E., Kamen, C., Ryan, J.L., Mustian, K.M., Janelsins, M.C., Peppone, L.J., Morrow, G.R., Roscoe, J.A. (2017) “Effects of Cognitive Behavioral Therapy for Insomnia and Armodafinil on Quality of Life in Cancer Survivors: A Randomized Placebo-Controlled Trial.” Journal of Cancer Survivorship. 11(3), 401-409. PMCID: PMC5437869.
  8. Peoples, A.R., Roscoe, J.A., Block, R.C., Heckler, C.E., Rylan, J.L., Mustian, K.M., Janelsins, M.C., Peppone, L.J., Moore, D.F., Coles, C., Hoelzer, K.L., Morrow, G.R., Dozier, A.M. (2017) “Nausea and Disturbed Sleep as Predictors of Cancer-Related Fatigue in Breast Cancer Patients: A Multicenter NCORP Study.” Supportive Care in Cancer, 25(4): 1271-1278. PMCID: PMC5323277.
  9. Mustian, K.M., Cole, C.L., Asare, M., Fung, C., Janelsins, M.C., Kamen, C.S., Peppone, L.J., Magnuson, A. (2016) “Exercise Recommendations for the Management of Symptoms Clusters Resulting from Cancer and Cancer Treatments: Fatigue, Cognitive Impairments, Insomnia, Distress, Functional Impairment, Sarcopenia, Cachexia and Bone Loss.” Oncology Nursing Forum, 32(4): 383-393. PMID: 27776835.
  10. Magnuson, A., Mohile, S.G., Janelsins, M.C. (2016) “Cognition and Cognitive Impairment in Older Adults with Cancer.” Current Geriatric Reports, 5(3): 213-219. PMCID: PMC4988403.
  11. Janelsins, M.C., Heckler, C.E., Stern, S., Thompson, B., Weston, D., Gross, R.A., Opanashuk, L.A., Cory-Slechta, D.A. (2016) “A Clinically Relevant Dose of Cyclophosphamide Chemotherapy Impairs Memory Performance on the Delayed Spatial Alternation Task that is Sustained Over Time as Mice Age.”  Neurotoxicology, 56: 287-293. PMCID: PMC5294923. Impact Factor: 3.38.
  12. Williams, A.M., Zent, C.S., Janelsins, M.C. (2016) “What We Know and What We Don’t Know About Chemotherapy- Related Cognitive Impairments in Patients with Hematological Malignancies.” British Journal of Hematology, 174(6): 835-846. PMID: 27391367. Impact Factor: 4.71.
  13. Loh, K.P., Janelsins, M.C., Mohile, S.G., Hsu, T., Kimmick, G.G., Lichtman, S., Wong, M., Ahles, T.A. (2016) “Chemotherapy-Related Cognitive Impairment in Older Patients with Cancer.” Journal of Geriatric Oncology, 7(4): 270-280. PMCID: PMC4969145.
  14. Karuturi, M., Wong, M., Hsu, T., Kimmick, G., Lichtman, S., Holmes, H., Inoye, S., Dale, W., Torke, A., Loh, M., Whitehead, Janelsins, M.C., Mohile, S.G. (2016) “Understanding Cognition in Older Patients with Cancer.” Journal of Geriatric Oncology, 7(4): 258-269. PMCID: PMC4969091.
  15. Conley, C.C., Heckler, C.E., Kamen, C.S., Janelsins, M.C., Morrow, G.R.,  Peppone, L.J., Scalzo, A.J., Gross, H., Dakhil, S., Mustian, K.M., Palesh, O.G. (2016) “Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy: A URCC CCOP Study.” Journal of Clinical Psychopharmacology, 36(1), 82-85. PMCID: PMC4689625.
  16. Williams, A., Janelsins, M.C., Van Wingaarden, E. (2016) “Cognitive Function in Cancer Survivors: Analysis of the 1999-2002 National Health and Nutrition Examination Survey.”  Supportive Care in Cancer, 24(5):2155-2162. PMCID: PMC4933958. Impact Factor: 2.50.   Note: (Dr. Janelsins is a co-senior author with Dr. Van Wingaarden)
  17. Janelsins, M.C., Peppone, L.J., Heckler, C.E., Kessler, S., Sprod, L.K., Atkins, J., Melnik, M., Kamen, C., Giguere, J., Mohile, S.G., Messino, M.J., Mustian, K.M. (2015) “YOCAS©® Yoga Reduces Self-Reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships between Memory and Sleep.” Integrative Cancer Therapies, Sept; 15(3):263-271. PMCID: PMC4884662. Impact Factor 2.36.
  18. Kamen, C., Heckler, C.E.., Janelsins, M.C., Peppone, L.J., McMahon, J.M., Morrow, G.R., Bowen, D., Mustian, K.M. (2015) “A Dyadic Exercise Intervention to Reduce Psychological Distress Among Lesbian, Gay, and Heterosexual Cancer Survivors.” LGBT Health, 3(1): 57-64. PMCID: PMC4770846.
  19. Kerns, S.L, Kundu, S., Hun Oh, J., Singhal, S.K., Janelsins, M.C., Travis, L.B., Deasy, J.O., Cecile, A., Janssens, J.W., Ostrer, M.P., Usmani, M., Rosenstein, B.S. (2015) “Predicting Radiotherapy Toxicity Using Single Nucleotide Polymorphism (SNP)-Based Models.” Seminars in Radiation Oncology, 25(4): 281-291. PMCID: PMC4576690.
  20. Mustian, K.M., Janelsins, M.C., Peppone, L.J., Kamen, C. (2015) “Yoga for the Treatment of Insomnia Among Cancer Patients: Evidence, Mechanisms of Action, and Clinical Recommendation.” Hematology and Oncology Rev, 10(2), 164-168. PMCID: PMC4386006.
  21. Kamen, C., Blosnich, J.R., Lytle, M., Janelsins, M.C., Peppone, L.J., Mustian, K.M. (2015) “Cigarette Smoking Disparities Among Sexual Minority Cancer Survivors.”  Preventive Medicine, 2:283-286. PMCID: PMC4430723.
  22. Peppone, L.J., Janelsins, M.C., Kamen, C., Mohile, S.G., Gewandter, J.S., Kirshner, J.J., Gaur, R., Ruzich, J., Esparaz, B.T., Mustian, K.M. (2015) “YOCAS©® Yoga for Musculoskeletal Symptoms Among Breast Cancer Survivors on Hormonal Therapy.” Breast Cancer Research and Treatment, 1-8. PMCID: PMC4467273.
  23. Kamen C., Mustian K.M., Heckler C.E., Janelsins M.C., Peppone L., Mohile S.G., McMahon J., Lord R., Flynn P.J., Weiss M., Spiegel D., Morrow G.R.. (2015) “The Association of Partner Support on Psychological Distress Among Prostate Cancer Patients in a Nationwide Study.” Journal of Cancer Survivorship, 9(3): 492-499. PMCID: PMC4510042.
  24. Sprod, L.K., Fernandez, I.D., Janelsins, M.C., Peppone, L.J., Atkins, J.N., Giguere, J., Block, R., and Mustian, K.M. (2014) “Effects of Yoga on Cancer-Related Fatigue and Global Side-Effect Burden in Older Cancer Survivors.”  Journal of Geriatric Oncology, 6(1), 8-14. PMCID: PMC4297736.
  25. Janelsins M.C., Kesler S., Ahles T.A., Morrow G.R. (2014) “Prevalence, mechanisms, and management of cancer-related cognitive impairment.”  Int Rev Psychiatry, 26(1):102-13. PMCID: PMC4084673. Impact Factor: 2.02; Cited 66 times.
  26. Kamen C., Tejani, M.A., Chandwani, K., Janelsins, M.C., Peoples AR, Roscoe JA, Morrow GR. (2014) “Anticipatory Nausea and Vomiting Due to Chemotherapy.” Eur J. Pharmacology, 722:172-9. PMCID: PMC3880638.
  27. Chandwani, K.D., Heckler, C.E., Mohile, S.G., Mustian, K.M., Janelsins M.C., Peppone, L.J., Bushunow, P., Flynn, P.J., Morrow, G.R. (2014) “Hot Flashes Severity, Complementary and Alternative Medicine Use, and Self-Rated Health in Women With Breast Cancer.” Explore, 10(4):241-247. PMCID: PMC4325272.
  28. Peppone, L.J., Mustian, K.M., Rosier, R.N., Carroll, J.K., Purnell, J.Q., Janelsins M.C., Morrow, G.R., Mohile, S.G. (2014) “Bone health Issues in Breast Cancer Survivors: A Medicare Current Beneficiary Survey (MCBS) Study.” Supportive Care Cancer, 22(1):245-51. PMCID: PMC4049181.
  29. Kesler, S., Hadi Hosseini, S.M., Heckler, C.E.., Janelsins, M.C., Palesh, O.G., Mustian, K.M., Morrow, G.R. (2013) “Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors.” Clinical Breast Cancer, 13(4):299-306. PMCID: PMC3726272.
  30. Mustian K.M., Sprod L.K., Janelsins M.C., Peppone L.J., Palesh O.G., Chandwani K., Reddy P.S., Melnik M.K., Heckler C., Morrow G.R. (2013) “A Multi-Center Randomized Controlled Trial of Yoga for Sleep Quality Among Cancer Survivors.” Journal of Clinical Oncology, 31(26):3233-3241. PMCID: PMC3757292.
  31. Janelsins M.C., Tejani M.A., Kamen C, Peoples A.R., Mustian K.M., Morrow G.R. (2013) “Current Pharmacotherapy for Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.”  Expert Opinion Pharmacotherapy, 14(6):757-66. PMCID: PMC3938333. Impact Factor: 3.53.
  32. Mustian, K.M., Sprod, L.K., Janelsins, M.C., Peppone, L.J., Mohile, S.G. (2012) “Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep Problems, Depression, Pain, Anxiety, and Physical Dysfunction—A Review.”  Oncology and Hematology Review, 8(2):81-88. PMCID: PMC3647480.
  33. Kesler, S., Hosseini, H., Hecker, C., Janelsins, M.C., Palesh, O.G., Mustian, K.M., Morrow, G.R. (2012) “Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors.” Clinical Breast Cancer, 13(4):299-306.  PMCID: PMC3726272.
  34. Palesh, O.G., Peppone, L.J., Innominato, P.F., Janelsins, M.C., Jeong, M., Sprod, L., Savard, J., Rotatori, M., Kesler, S., Telli, M., Mustian, K.M. (2012) “Prevalence, Putative Mechanisms, and Current Management of Sleep Problems During Chemotherapy for Cancer.”  Nature and Science of Sleep, 4:151-162. PMCID: PMC3593248.
  35. Palesh O.G., Mustian KM, Peppone LJ, Janelsins M.C., Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR. (2012)  “Impact of Paroxetine on Sleep Problems in 426 Cancer Patients Receiving Chemotherapy: A Trial From the University of Rochester Cancer Center Community Clinical Oncology Program.” Sleep Medicine, 13(9):1184-1190. PMCID: PMC3664933.
  36. Kesler, S.R., Janelsins, M.C., Koovakkattu, D., Palesh, O.G. Mustian, K.M., Morrow, G.R., Dhabhar, F. (2012)  “Reduced Hippocampal Volume Associated with Pro-inflammatory Peripheral Cytokine Levels in Chemotherapy-treated Breast Cancer Survivors.” Brain, Behavior, and Immunity, 30 Suppl: S109-116. PMCID: PMC3665606.
  37. Chandwani, K., Ryan, J.L., Peppone, L.J., Janelsins, M.C., Sprod, L.K., Devine-Recuay, K., Trevino, L., Gewandter, J., Morrow, G.R., Mustian, K.M. (2012) “Cancer-related Stress and Complementary and Alternative Medicine: a review.” Evidenced-Based Complementary and Alternative Medicine, PMCID: PMC3403456.
  38. Kirshner, J.J., Heckler, C.E., Janelsins, M.C., Dakhil, S., Hopkins, J.O., Coles, C., Morrow, G.R. (2012). ”Prevention of Pegfilgrastim-Induced Bone Pain: A Phase III Double-Blind Placebo-Controlled Randomized Clinical Trial of the Effects of Naproxen from of the University of Rochester Cancer Center Clinical Community Oncology Program Research Base.” Journal of Clinical Oncology, 2012 Jun 1; 30(16):1974-1979. PMCID: PMC3383174.
  39. Sprod, L.K., Janelsins, M.C., Palesh, O.G., Carroll, J.K., Heckler, C.E., Peppone, L.J., Mohile, S.G., Morrow, G.R., Mustian, K.M. (2012) “Health-Related Quality of Life and Biomarkers in Breast Cancer Survivors Participating in Tai Chi Chuan.” Journal of Cancer Survivorship, 6(2):146-154. PMCID: PMC3664952.
  40. Sprod, L.K., Mohile, S.G., Demark-Wahnefried, W., Janelsins, M.C., Morrow, G.R., Lord, R., Gross, H. and Mustian, K.M. (2012) “Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients.” Journal of Geriatric Oncology, 3(2):90-97. PMCID: PMC3376161.
  41. Peppone LJ, Rickles A, Janelsins M.C., Insalaco M, Skinner KA. (2012)  “The Association between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels.” Annals of Surgical Oncology, 19(8):2590-2599. PMCID: PMC4158737.
  42. Janelsins, M.C., Mustian, K.M., Palesh, O.G., Mohile, S.G., Peppone, L.J., Sprod, L.K., Roscoe, J.A., Katz, A.W.., Williams, J.K., Morrow, G.R. (2012)  “Differential Expression of Cytokines in Breast Cancer Patients Receiving Different Chemotherapies: Implications for Cognitive Impairment Research.”  Supportive Care in Cancer, 20(4):831-839. PMCID: PMC3218259. Impact Factor: 2.50; Cited 48 times.
  43. Sprod, L.K., Janelsins, M.C., Palesh, O.G., Carroll, J.K., Heckler, C.E., Peppone, L.J., Mohile, S.G., Morrow, G.R., Mustian, K.M.  (2012) “Health-Related Quality of Life and Biomarkers in Breast Cancer Survivors Participating in Tai Chi Chuan.” Journal of Cancer Survivorship, 6(2):146-54. PMCID: PMC3664952.
  44. Mohile, S.G., Heckler, C.E., Fan, L., Mustian, K.M., Jean-Pierre, P.J., Usuki, K., Sprod, L.K., Janelsins, M.C., Purnell, J., Peppone, L.J., Palesh, O.G., Devine, K., Morrow, G.R.  (2011) “Age-related Differences in Symptoms and Their Interference with Quality of Life in 903 Cancer Patients Undergoing Radiation Therapy.” Journal of Geriatric Oncology, 2(4):225-232. PMCID: PMC3415272.
  45. Janelsins M.C., Mustian K.M., Peppone L.J., Sprod L.K., Shayne M, Mohile S, Chandwani K, Gewandter J.S., Morrow G.R. (2011) “Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.” Journal of Cancer Science Therapy, 29(S2): S2-001. PMCID: PMC3408313.
  46. Peppone L.J., Mustian K.M., Morrow G.R., Dozier A.M., Ossip D.J., Janelsins M.C., Sprod L.K., McIntosh S. (2011) “The Effect of Cigarette Smoking on Cancer Treatment-Related Side Effects.” The Oncologist, 16(12):1784-1792. PMCID: PMC3248778.
  47. Janelsins, M.C., Kohli, S., Mohile, S.G., Usuki, K., Ahles, T.A., Morrow, G.R. (2011) “An Update on Cancer- and Chemotherapy-Related Cognitive Difficulties: State of the Field and Possible Mechanisms.” Sem. Oncology, 38(3):431-438. PMCID: PMC3120018. Impact Factor: 3.95; Cited 104 times.
  48. Janelsins, M.C., Davis, P.D., Wideman, L., Katula, J., Sprod, L., Peppone, L.J., Palesh, O.G., Heckler, C.E., Williams, J., Morrow, G.R., Mustian, K.M.  (2011)  “Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors.”  Clinical Breast Cancer, 11(3):161-170. PMCID: PMC3156577. Impact Factor: 2.107; Cited 71 times.
  49. Palesh, O.G., Demark-Wahnefried, W., Mustian, K.M., Rowland, J., Minasian, L., Sprod, L.K., Janelsins, M.C., Peppone, L.J., Sloan, J., Basen-Engquist, W., Jones, L., Buist, D., Paskett, E. (2011) “Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology.”  Cancer Epidemiol Biomarkers Prev, 20(5):1050-1055. PMCID: PMC3124556.
  50. Mohile, S.G., Fan, L., Jean-Pierre, P., Mustian, K.M., Peppone, L.J., Janelsins, M.C., Morrow, G.R. (2011) “The Impact of Cancer on Geriatric Syndromes in Older Medicare Beneficiaries.” Journal of Clinical Oncology, 29(11):1458-1464. PMCID: PMC3082984.
  51. Mustian, K.M., Sprod, L.K., Janelsins, M.C., Devine, K.R., Peppone, L.J., & Mohile, S.G.  (2011) “Chemotherapy-induced Nausea and Vomiting.”  U.S. Oncology, 7(2):91-97. PMCID: PMC3898599.
  52. Peppone, L.J., Huston, A.J., Reid, M.E., Rosier, R.N., Zakharia, Y, Trump, DL, Mustian, KM, Janelsins, M.C., Purnell, J.Q., Morrow, G.R. (2011) “The effects of various vitamin D supplementation regimens in breast cancer patients.” Breast Cancer Research & Treatment, 127(1):171-177. PMCID: PMC3085185.
  53. Sprod, L.K., Palesh, O.G., Janelsins, M.C., Peppone, L.J., Heckler, C.E., Adams, M.J., Morrow, G.R., Mustian, K.M. (2010) “Exercise, Sleep Quality and Mediators of Sleep in Breast and Prostate Cancer Patients Receiving Radiation Therapy.” Comm. Oncology, 7(10):463-471. PMCID: PMC3026283.
  54. Jean-Pierre, P.J, Morrow, G.R., Roscoe, J.A., Heckler, C.E., Mohile, S. G., Janelsins, M.C., Peppone, L.J., Hemstad, A., Esparaz, B.T., Hopkins, J.O. (2010) “A Phase III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of the Effect of Modafinil on Cancer-Related Fatigue Among 631 Patients Receiving Chemotherapy: A URCC CCOP Research Base Study.” Cancer, 116(14):3513-20. PMCID: PMC2941794.
  55. Peppone, L. J., Mustian, K. M., Janelsins, M.C., Palesh, O.G., Rosier, R., Piazza, K., Purnell, J., Darling, T., Morrow, G. R. (2010) “Effects of a Structured Weight-Bearing Exercise Program on Bone Metabolism Among Breast Cancer Survivors: A Feasibility Trial.” Clinical Breast Cancer, 10(3):224-229. PMCID: PMC3071508.
  56. Janelsins, M.C., Roscoe, J.A., Berg, M.J., Heckler, C.E., Thompson, B.D., Gallagher, M.J., Morrow, G.R., Jean-Pierre, P., Opanashuk, L.A., Gross, R.A. (2010) “IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 mice.”  Cancer Investigation, 28(5):544-553. PMCID: PMC3024545. Impact Factor: 2.22; Cited 41 times.
  57. Palesh, O.G., Roscoe, J.A., Mustian, K.M., Roth, T., Savard, J., Ancoli-Israel, S., Purnell, J.Q., Janelsins, M.C., Heckler, C.E., Morrow, G.R. (2010) “Prevalence, Demographics and Psychological Associations of Sleep Disruption in 823 Cancer Patients: URCC CCOP.” Journal of Clinical Oncology, 28(2):292-298. PMCID: PMC2815717.
  58. Mustian, K.M., Sprod, L.K., Palesh, O.G., Peppone, L.J., Janelsins, M.C., Mohile, S.G., Carroll, J. (2009) “Exercise for the Management of Side Effects and Quality of Life Among Cancer Survivors.” Current Sports Medicine Reports, 8(6):325-330. PMCID: PMC2875185.
  59. Mustian, K.M., Peppone, L.J., Palesh, O.G., Janelsins, M.C., Mohile, S.G., Purnell, J.Q., Darling, T.V. (2009) “Exercise and Cancer-Related Fatigue.” U.S. Oncology, 5(2):20-23. PMCID: PMC3156559.
  60. Desai, M.K., Sudol, K.L., Janelsins, M.C., Mastrangelo, M.A., Frazer, M.E., Bowers, W.J. (2009) “Triple-transgenic Alzheimer's Disease Mice Exhibit Region-Specific Abnormalities in Brain Myelination Patterns Prior to Appearance of Amyloid and Tau Pathology.” Glia, 57(1):54-65. PMCID: PMC2584762.
  61. Mustian, K.M., Darling, T.V., Janelsins, M.C., Jean-Pierre, P.J, Roscoe, J.A., Morrow, G.R. (2008) “Chemotherapy-Induced Nausea and Vomiting.” US Oncology, Volume 4:19-23. PMCID: PMC3994039.
  62. Janelsins, M.C., Mastrangelo, M.A., Park, K.M., Sudol, K.L., Narrow, W.C., Oddo, S., LaFerla, F.M., Callahan, L.M., Federoff, H.J., Bowers, W.J. (2008) “Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice.”  American Journal of Pathology, 173(6):1768- 1772.  PMCID: PMC2626388. Impact Factor: 4.59; Cited 98 times.
  63. Janelsins M.C., Mastrangelo M.A., Oddo S, LaFerla F.M., Federoff H.J., Bowers W.J. (2005) “Early Correlation of Microglial Activation with Enhanced Tumor Necrosis Factor-Alpha and Monocyte Chemoattractant Protein-1 Expression Specifically Within the Entorhinal Cortex of Triple Transgenic Alzheimer's Disease Mice.” Journal of Neuroinflammation. 2:23. PMCID: PMC1276812. Impact Factor: 5.41; Cited 156 times.


  1. Magnuson, A., Janelsins, M.C. (2017) “Relationships Between Cognitive Impairments in Breast Cancer Survivors and Menopause.” In: periFACTS. Rochester, NY.
  2. Mustian, K.M., Sprod, L.K., Janelsins, M.C., Peppone, L.K., Carroll, J., Mohile, S., Palesh, O. (2013) Exercise for Cancer Patients: Treatment Side Effects and Quality of Life. In: Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer Their Causes and Their Management. In: Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer, Their Causes, and Their Management. New York, NY. Pp 279-289.
  3. Bowers, W.J., Janelsins, M.C., and Federoff, H.J. Application to gene therapy and vaccination. (2008) In: Neuroimmune Pharmacology. Ed. T. Ikezu and H. Gendelman. Springer, New York, NY.  Pgs. 709-724.  



  1. Janelsins, M.C., Peppone, L.J., Heckler, C.E., Kamen, C., Mohile, S.G., Magnuson, A., Mustian, K.M., Kleckner, I., Young, K.R., Conlin, A.K., Weiselberg, L.R., Mitchell, J.W., Ahles, T., Morrow, G.R. (2016) “ Longitudinal Trajectory of Cancer-Related Cognitive Impairment up to Six-Months Post-Chemotherapy: A Nationwide NCORP Study in 839 Breast Cancer Patients and Non-Cancer Controls.” American Society of Clinical Oncology, Chicago, IL. The Journal of Clinical Oncology. Abstract #171252.
  2. Janelsins, M.C., Yao, S., Mustian, K., Peppone, L., Heckler, C., Ambrosone, C., Morrow, G. “IGF-1 is Associated with Improved Memory Function in Breast Cancer Patients Receiving Chemotherapy.” 35th Society of Behavioral Medicine Meeting, Philadelphia, PA.  
  3. Janelsins, M.C., Heckler, C.E., Peppone, L., Atkins, J., Melnik, M., Giguere, J., Frizzell, B. 2013 YOCAS©® “Yoga, Fatigue, and Memory Difficulty: Results from a URCC CCOP Randomized, Controlled Clinical Trial among 358 Cancer Survivors.” Society of Behavioral Medicine 34th Annual Meeting, San Francisco, CA.
  4. Janelsins, M.C, Roscoe, J., Mustian, K., Palesh, O., Peppone, L. Sprod, L., Morrow, G. 2010. “Characterization of inflammatory markers that may relate to chemo brain in 54 breast cancer patients receiving chemotherapy.” MASCC/ISOO International Symposium – Supportive Care in Cancer, Vancouver, CA.
  5. Janelsins, M.C., Roscoe J, Mustian K, Palesh O, Peppone L, Sprod L, Morrow G. 2010. “Expression of Inflammatory Molecules Among Breast Cancer Patients Receiving Different Chemotherapies:Implications for Chemobrain.” The 34th Annual Meeting of the Society of Preventive Oncology, Bethesda, M.D.
  6. Janelsins, M.C., Mastrangelo, M.A., Park, K.M., Sudol, K.L., Frazer, M., Narrow, W.C., Oddo, S., LaFerla, F.M., Callahan, L.M., Federoff, H.J., Bowers, W.J. 2008. “Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.” The 38th Annual Meeting of the Society of Neuroscience, Washington, D.C.